Clinivation WorldView is the medical device and diagnostic industry's most comprehensive, authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory Intelligence. Providing clear, step-by-step market clearance regulations, processes, and guidance for >99% of the world markets, only clinivation WorldView delivers tried-and-true intelligence from certified, practicing professionals with real-world experience.

Since 2001, Inverness Medical, the world's sixth largest in vitro diagnostics company, has focused on the development, manufacture and marketing of advanced consumer and professional medical diagnostic products.

In January 2008, Inverness Medical acquired Panbio Limited - a leading developer of tests used in the diagnosis of flaviviruses and other arthropod-borne viruses. Panbio was first-to-market with diagnostics for Ross River virus, West Nile virus, Japanese Encephalitis and dengue fever and its range of technical platforms includes enzyme-linked immmunosorbant assay (ELISA) and rapid lateral flow technology.

Now Inverness Medical Innovations Australia, Panbio^® lives on as a premium Australian brand of diagnostic products within the global Inverness medical portfolio. The Panbio^® range of dengue diagnostics leads the world in dengue detection.

For more information, please visit www.invernessmedical.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.

Our core brands include the clinivation Global xi market clearance platform, clinivation WorldView on-demand regulatory intelligence, and clinivation Clinical Suite and clinivation Registry Suite electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.